01.11.2002 | Case Reports
Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range
Erschienen in: Annals of Nuclear Medicine | Ausgabe 7/2002
Einloggen, um Zugang zu erhalten